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LETTER TO THE EDITOR 
PSYCHOTROPIC DRUGS : WHAT'S IN A NAME ? 
Sir, 
Shamasundar (1992) listed different 
psychotropic drugs with closely similar brand 
names, and suggested that confusion may arise in 
dispensing these preparations. A case is reported 
below where such a situation indeed did arise. 
Mr. A, a 25 year old student suffering from 
Major Depression with melancholia (DSM-IV), 
had been started on fluoxetine (Prodep) 20 mg/ 
day by his previous psychiatrist. At follow-up a 
month later, he showed satisfactory improve-
ment, and the psychiatrist renewed the prescrip-
tion with a different brand of the same drug 
(Flumeg). 
Within a week, A's clinical state rapidly 
deteriorated. There was a recurrence of depres-
sive thought, and pronounced fatigue, lethargy, 
drowsiness and psychomotor slowing. He was 
brought to this author for a second opinion. 
On the surface, it appeared that A had 
replapsed into depression. The reason for the 
marked severity of symptoms was unclear - until 
A took out a strip of his current medication and 
showed it. The drug was penfluridol, not 
fluoxetine. 
When A had his second prescriiption filled 
out, the pharmacist had dispensed 'Flumap' in-
stead of 'Flumeg'. The two names are closely 
similar ; even the difference in the.last 2 letters 
can be obscured if the physician has the style of 
writing 'g' in reverse, as many indeed do ; also, 
both drugs are available in 20 mg strengths. The 
likelihood of a mix-up, such as occurred with Mr 
A, is therefore great. One wonders how often 
such a mix up happens. 
Shamasundar (1992) did not mention the 
Flumeg/Flumap similarity but reported other closely 
similar names : Seradol (haloperidol), Seridac 
(mianserin) and Serodep (trazodone); Mezatil 
(chlorpromazine) and Mazetol (carbamazepine); 
Anxipar (buspirone) and Anxipax (alprazolam); 
Elewal (doxepin) and Eliwel (amitriptyline) etc. 
Other similarities not reported by 
Shamasundar include Epilent (carbamazepine) and 
Epilex (sodium valproate); Traz (lorazepam), 
Trazine (trifluperazine) and trazonil (trazodone); 
Melleril (thioridazine) and Mezaril (carbamazepine) 
etc. And, Lozapin is not loxapine but clozapine ! 
The problem with similar brand names is 
that if a clinician unfamiliar with a brand sees it 
on a prescription he may misconstrue the pa-
tient's treatment history ; if the pharmacist is 
unfamiliar with the brand he may dispense the 
wrong drug. 
The best way to resolve the issue is for 
clinicians to routinely specify the pharmacologi-
cal name of the drug in parenthesis after the 
brand name on the prescription. It may also be 
useful if, on the reverse of the prescription, 
alternate brand names are written should the 
prescribed brand be unavailable. And, it would 
help if the prescription is legibly written ! 
In view of the mushrooming number of 
pharmaceutical concerns venturing into the 
psychotropic segment, there is also a need for an 
official representation (such as by the Indian 
Psychiatric Society) to an official organization 
(such as the Drug Controller of India, and the 
various pharmaceutical concerns themselves) for 
the monitoring and prevention of registration of 
similar brand names for different psychotropic 
drugs. 
It is hoped that this report will heighten the 
awareness of the problems created by brand 
names that have been selected without due care. 
ChittaranjanAndrade, M.D. Associate pro-
fessor, Department ofPsychopharmacology. Na-
tional Institute of mental Health and 
Neurosciences, Bangalore 560 029. 
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